Thrombosis Canada/LinkedIn
Dec 6, 2025, 06:25
Dr. Jeff Weitz Unpacks the Latest ROXI-VTE Trials
Thrombosis Canada shared a new post on LinkedIn:
“New episode!
We sat down with Dr. Jeff Weitz to unpack the latest ROXI-VTE trials and what the data could mean for the future of thrombosis prevention.
If you manage patients at risk of VTE, don’t miss this conversation—full of clinical insights, context, and what’s coming next.
Episode goes live across all platforms within 24 hours, but if you can wait, listen to it here.
Title: ROXI-VTE Trials Explained: Dr. Jeff Weitz on Next-Generation Thrombosis Prevention”
Get the latest with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?